Clinact   Report issue

For profit Phase 2 Phase 4
Founded: Sevres France (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2006
NCT00247052
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinact

Active Ingredients

Drugs in Phase 4 Trials (2)

diclofenac (voltaren) (1 trial)

fluorouracil (efudex) (1 trial)

Drugs in Phase 2 Trials (1)

ovx836 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pericardial Effusion (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3